To compare the detection performance of near-, mid-, and far-infrared laser fuzes in clouds, we built a laser fuze detection model in a cloud environment based on the Monte Carlo method, and simulated the echoes of near- (0.86 μm), mid- (4.6 μm), and far-infrared (10 μm) pulsed laser fuzes in clouds under two scenarios: the cloud backscattering echo in the absence of a target in clouds and the target echo in the presence of a target in clouds. The echoes of laser fuzes at different wave bands under two scenarios were compared, and the results show that the mid- and far-infrared laser fuzes have comparable detection performance in clouds, while presenting respective advantages and disadvantages compared to the fuze in the near-infrared wave band. With presentation of the detection performance comparison results between the near-, mid-, and far-infrared laser fuzes in clouds, this paper can provide guidance and reference for the application of mid- and far-infrared lasers in the laser fuze field.
1 January 2021 in Archives of Clinical and Biomedical Research
Human respiratory syncytial virus (hRSV) has evaded active vaccination or effective antiviral therapy for decades and continues to be the leading cause of morbidity and hospitalization in infants, the elderly, and the immunocompromised worldwide. Inadequate understanding of the antigenic intricacies of its viral proteins and the immune responses they generate in the host is the greatest obstacle to the progress of hRSV prevention and treatment. Currently, the prefusion F protein is considered the most effective antigen for inducing protective immunity. Other molecular components of hRSV, such as the G or N proteins, have also been explored as potential targets for disease control. However, important knowledge gaps remain about the role played by various hRSV proteins in immunobiology and pathology. This review summarizes the unique immunomodulatory aspects of hRSV infection, the viral proteins involved in intracellular immune signaling, and the viral interactions in play with the host’s immune system.